Cargando…
The OxyMask(™) development and performance in healthy volunteers
BACKGROUND: The OxyMask(™) is a unique, open-style, oxygen mask that was originally developed in 2005. The original mask was modified, using computational fluid dynamics numerical simulations, with the goal of allowing it to produce a wider range of FiO(2). This analysis was used to guide the modifi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417856/ https://www.ncbi.nlm.nih.gov/pubmed/22915909 |
_version_ | 1782240548887724032 |
---|---|
author | Paul, James E Hangan, Horia Hajgato, Julius |
author_facet | Paul, James E Hangan, Horia Hajgato, Julius |
author_sort | Paul, James E |
collection | PubMed |
description | BACKGROUND: The OxyMask(™) is a unique, open-style, oxygen mask that was originally developed in 2005. The original mask was modified, using computational fluid dynamics numerical simulations, with the goal of allowing it to produce a wider range of FiO(2). This analysis was used to guide the modification of the mask shell and the location for the oxygen diffuser. METHODS: The new OxyMask was attached to 10 healthy subjects and used to deliver escalating levels of oxygen (1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 and 30 LPM) for 90 seconds at each level and the resulting FiO(2) was recorded (at the lips) from 5 consecutive measurements at each oxygen flow rate. RESULTS: Mean FiO(2) was 25.4% at 1.5 LPM of oxygen, 30.1% at 2 LPM, 36.5% at 2.5 LPM, 41.8% at 3 LPM, 57.6% at 5 LPM, 74.4% at 10 LPM, and 80.1% at 15 LPM. Each FiO(2) achieved at these escalating oxygen levels was significantly greater than all the previous levels. The mean FiO(2) was 82.8 at 20 LPM, 84.2% at 25 LPM and 84.3% at 30 LPM. All of these values on average were not significantly greater than the FiO(2) achieved with 15 LPM. In a few subjects a maximum FiO(2) of 90% was reached. CONCLUSION: The original OxyMask was successfully modified so that the second generation of the mask can provide a wide range of FiO(2), from 25% to 90%, while keeping its unique open design. |
format | Online Article Text |
id | pubmed-3417856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34178562012-08-22 The OxyMask(™) development and performance in healthy volunteers Paul, James E Hangan, Horia Hajgato, Julius Med Devices (Auckl) Original Research BACKGROUND: The OxyMask(™) is a unique, open-style, oxygen mask that was originally developed in 2005. The original mask was modified, using computational fluid dynamics numerical simulations, with the goal of allowing it to produce a wider range of FiO(2). This analysis was used to guide the modification of the mask shell and the location for the oxygen diffuser. METHODS: The new OxyMask was attached to 10 healthy subjects and used to deliver escalating levels of oxygen (1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 and 30 LPM) for 90 seconds at each level and the resulting FiO(2) was recorded (at the lips) from 5 consecutive measurements at each oxygen flow rate. RESULTS: Mean FiO(2) was 25.4% at 1.5 LPM of oxygen, 30.1% at 2 LPM, 36.5% at 2.5 LPM, 41.8% at 3 LPM, 57.6% at 5 LPM, 74.4% at 10 LPM, and 80.1% at 15 LPM. Each FiO(2) achieved at these escalating oxygen levels was significantly greater than all the previous levels. The mean FiO(2) was 82.8 at 20 LPM, 84.2% at 25 LPM and 84.3% at 30 LPM. All of these values on average were not significantly greater than the FiO(2) achieved with 15 LPM. In a few subjects a maximum FiO(2) of 90% was reached. CONCLUSION: The original OxyMask was successfully modified so that the second generation of the mask can provide a wide range of FiO(2), from 25% to 90%, while keeping its unique open design. Dove Medical Press 2008-12-11 /pmc/articles/PMC3417856/ /pubmed/22915909 Text en © 2009 Paul et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Paul, James E Hangan, Horia Hajgato, Julius The OxyMask(™) development and performance in healthy volunteers |
title | The OxyMask(™) development and performance in healthy volunteers |
title_full | The OxyMask(™) development and performance in healthy volunteers |
title_fullStr | The OxyMask(™) development and performance in healthy volunteers |
title_full_unstemmed | The OxyMask(™) development and performance in healthy volunteers |
title_short | The OxyMask(™) development and performance in healthy volunteers |
title_sort | oxymask(™) development and performance in healthy volunteers |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417856/ https://www.ncbi.nlm.nih.gov/pubmed/22915909 |
work_keys_str_mv | AT pauljamese theoxymaskdevelopmentandperformanceinhealthyvolunteers AT hanganhoria theoxymaskdevelopmentandperformanceinhealthyvolunteers AT hajgatojulius theoxymaskdevelopmentandperformanceinhealthyvolunteers AT pauljamese oxymaskdevelopmentandperformanceinhealthyvolunteers AT hanganhoria oxymaskdevelopmentandperformanceinhealthyvolunteers AT hajgatojulius oxymaskdevelopmentandperformanceinhealthyvolunteers |